Improving access to substance use services and preventing overdoses in Oregon
Supporting data-driven decision-making to support substance use service expansion policies and to prevent overdoses
['FUNDING_OTHER'] · CHESTNUT HEALTH SYSTEMS, INC. · NIH-11122953
This study is all about helping people in Oregon get better access to services for substance use, like opioids and meth, by sharing useful information that can help decision-makers reduce overdose rates and fill in the gaps where help is needed most.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CHESTNUT HEALTH SYSTEMS, INC. (nih funded) |
| Locations | 1 site (BLOOMINGTON, UNITED STATES) |
| Trial ID | NIH-11122953 on ClinicalTrials.gov |
What this research studies
This research focuses on gathering and sharing actionable data to help decision-makers in Oregon improve access to substance use services and reduce overdose rates. By leveraging a new policy that increases funding for these services, the project aims to provide relevant data in user-friendly formats to support timely and informed decisions. The goal is to address significant service gaps in the state, particularly for opioid and methamphetamine use, and to evaluate the impact of these services on the community.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Oregon who are affected by substance use issues, particularly those struggling with opioid and methamphetamine use.
Not a fit: Patients who do not reside in Oregon or who are not affected by substance use issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to substance use services and a reduction in overdose incidents in Oregon.
How similar studies have performed: Other research has shown success in using data-driven approaches to improve substance use services and outcomes, indicating that this approach has potential.
Where this research is happening
BLOOMINGTON, UNITED STATES
- CHESTNUT HEALTH SYSTEMS, INC. — BLOOMINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CRUDEN, GRACELYN — CHESTNUT HEALTH SYSTEMS, INC.
- Study coordinator: CRUDEN, GRACELYN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.